Jasper Therapeutics Inc (JSPR)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -12.71M | -13.75M | -13.95M | -17.83M | -19.36M | -17.73M | -15.07M | -15.99M |
Pre Tax Income | -11.86M | -13.21M | -14.26M | -16.08M | -17.54M | -16.58M | -13.73M | -14.58M |
Net Income | -11.86M | -13.21M | -14.26M | -16.08M | -17.54M | -16.58M | -13.73M | -14.58M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -7.09M | -18.8M | -14.78M | -17.52M | -18.98M | -17.82M | -15.11M | -16.03M |
EBITDA | -12.44M | -13.47M | -13.67M | -17.55M | -19.09M | -17.44M | -14.78M | -15.69M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -136k | -935k | -36.83M | -51.2M | -68.86M |
Pre Tax Income | 18k | -552k | -30.64M | -37.69M | -64.47M |
Net Income | 2k | -591k | -30.64M | -37.69M | -64.47M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | -0.091 | -0.685 | -0.839 | -0.544 |
EBIT | -136k | -935k | -36.91M | -50.61M | -69.09M |
EBITDA | -136k | -935k | -36.46M | -50.22M | -67.75M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.